Paul Seixas Favouritism Claims Rejected by Anti-Doping Chiefs 2026

Paul Seixas favouritism accusations have been firmly rejected by anti-doping authorities at the Tour de France, following complaints from rival riders about unequal testing protocols. The International Testing Agency (ITA) and the UCI have defended their decision to subject certain riders to nocturnal tests while sparing the 19-year-old French home favourite, who sits fourth overall.

What Sparked the Favouritism Allegations?

The controversy erupted when Matej Mohoric, a Slovenian rider for Bahrain Victorious, revealed he was tested at 5 a.m. on Tuesday morning. Mohoric pointed out that Paul Seixas, riding for Decathlon CMA CGM, had not undergone a similar night-time test, despite being a top contender. “It would be good to guarantee equal treatment for everyone,” Mohoric said, implying a double standard.

ITA and UCI Response: No Bias in Testing

The ITA, which manages the anti-doping programme for the Tour de France, categorically denied any bias. In a statement, the ITA explained: “Our decisions are based on facts, risk assessments, performances, scientific results and insights, intelligence and investigations, as well as data analysis. This approach enables us to act as precisely and impartially as possible.” The agency emphasised that the French anti-doping agency (AFLD) only provides occasional support and does not influence which riders are selected for nocturnal controls.

The UCI, professional cycling’s governing body, endorsed the ITA’s regime but stressed that night-time testing remains an “exceptional measure, reserved for limited and justified circumstances.” Both organisations insist that Paul Seixas has not been given preferential treatment.

Comparison of Testing Protocols

Key Takeaways from the Controversy

• Paul Seixas has not faced a nocturnal anti-doping test, unlike race leader Pogacar and former top contender Vingegaard.
• Riders like Mohoric feel the system lacks transparency and equal treatment.
• ITA maintains its selection process is purely data-driven and impartial.
• UCI confirms night-time tests are only used in exceptional, justified situations.
• The incident has sparked wider debate about fairness in anti-doping enforcement.

FAQ: Understanding the Paul Seixas Testing Controversy

The debate over Paul Seixas and unequal testing highlights the delicate balance between targeted anti-doping measures and the perception of fairness. While the ITA’s data-driven approach aims to maximise efficiency, riders and fans alike are demanding greater transparency. As the Tour de France continues, all eyes remain on the testing protocols and whether every competitor is truly being treated equally.

For now, the official stance is clear: no favouritism exists, and the system is designed to be impartial. Yet the cries of foul from the peloton suggest that the conversation around anti-doping equity is far from over.